MedPath

RIZZA STEFANO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

Not Applicable
Completed
Conditions
Type2 Diabetes
Interventions
First Posted Date
2019-12-09
Last Posted Date
2021-08-03
Lead Sponsor
Stefano Rizza
Target Recruit Count
35
Registration Number
NCT04190160
Locations
🇮🇹

Stefano Rizza, Roma, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.